Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Review Article

Potential Neuroprotective Role of Neurotrophin in Traumatic Brain Injury

Author(s): Rei Shian Yap, Jaya Kumar and Seong Lin Teoh*

Volume 23, Issue 10, 2024

Published on: 25 January, 2024

Page: [1189 - 1202] Pages: 14

DOI: 10.2174/0118715273289222231219094225

Price: $65

Abstract

Traumatic brain injury (TBI) is a major global health issue that affects millions of people every year. It is caused by any form of external force, resulting in temporary or permanent impairments in the brain. The pathophysiological process following TBI usually involves excitotoxicity, mitochondrial dysfunction, oxidative stress, inflammation, ischemia, and apoptotic cell death. It is challenging to find treatment for TBI due to its heterogeneous nature, and no therapeutic interventions have been approved thus far. Neurotrophins may represent an alternative approach for TBI treatment because they influence various functional activities in the brain. The present review highlights recent studies on neurotrophins shown to possess neuroprotective roles in TBI. Neurotrophins, specifically brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) have demonstrated reduced neuronal death, alleviated neuroinflammatory responses and improved neurological functions following TBI via their immunomodulatory, anti-inflammatory and antioxidant properties. Further studies are required to ensure the efficacy and safety of neurotrophins to be used as TBI treatment in clinical settings.

Keywords: Traumatic brain injury, brain-derived neurotrophic factor, nerve growth factor, neurotrophin, cell-based therapy, nanoparticles, biomaterials.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy